Abstract: In one aspect, a device is provided. The device comprises at least one detection unit which generates an output signal in accordance with a status of a transmission path. Accordingly, switching of a telephone between two transmission paths is controlled in a simple manner in accordance with the output signal.

Abstract: An airbag device for protecting a vehicle occupant in case of a crash, including at least one region that can be inflated with gas, which in the inflated state forms a gas cushion for a vehicle occupant to be protected in the form of a side airbag, at least a first material layer of the inflatable region extending in front of a lateral vehicle structure of a motor vehicle in the inflated state of the airbag device, and at least a second material layer of the inflatable region of the inflatable region, that opposes the first material layer in the inflated state of the airbag device, wherein at least one fastening flap is provided at the airbag device via which the airbag device can be fastened to a motor vehicle structure.

Abstract: The present application relates to the use of helium-oxygen gas mixtures for the treatment and/or prophylaxis of primary and secondary forms of pulmonary hypertension (PH) and also to the combination of drugs and helium-oxygen gas mixtures, wherein the gas mixtures are used as carrier gases to improve the introduction of a drug for the treatment and/or prophylaxis of pulmonary hypertension.

Abstract: A device for gassing a liquid, particularly for membrane facilities used in immersion operation, has a gas supply channel and at least one gas lance from which a gas flow exits in gassing operation. The gas lance is connected to the gas supply channel via at least one connection channel including a first mouth area on the side of the gas lance and a second mouth area on the side of the gas supply channel and generating as a throttle a flow pressure loss of the gas flow entering the gas lance. Below the first mouth area an extension section is provided, which adjoins the gas lance and has an opening below the first mouth area.

Abstract: The present invention relates to pharmaceutical compositions for treating, preventing or managing heart failure and/or connected diseases therewith comprising at least a diaryl urea compound optionally combined with at least one additional therapeutic agent. Useful combinations include e.g. BAY 43-9006 as a diaryl urea compound.

Abstract: The present invention relates to methods for determining the efficiency of an ion channel ligand comprising (a) contacting a cell expressing the ion channel with (i) plasma of an animal and (ii) the ion channel ligand and (b) determining the effect of the ion channel ligand on the cell.

Abstract: The present invention is directed to a method identifying a risk for a thrombogenic disorder including, without limitation, atrial fibrillation, stroke, prolonged intermitted neurological deficit (PRIND), transitory ischemic attack (TIA), atherosclerotic cerebrovascular disease (CVD) and/or coronary heart disease, as well as to a method for selecting patients with a risk for a thrombogenic disorder, to a method for identifying a pharmaceutical for the therapy or prophylaxis of a thrombogenic disorder as well as to a method for producing a medicament and a diagnostic by employing the TAFI-Ile347 polymorphism.

Abstract: A cyanide-free electrolyte composition for the galvanic deposition of a copper layer on substrate surfaces and a method for the deposition of such layers. The electrolyte composition comprises at least copper(II) ions, a hydantoin and/or hydantoin derivative, a di- and/or tricarboxylic acid or salts thereof, and a metalate of an element of the group consisting of molybdenum, tungsten and vanadium and/or a cerium compound.

Abstract: The present invention is directed to a method identifying a risk for a thrombogenic disorder, to a method for selecting patients with a risk for a thrombogenic disorder, to a method for identifying a pharmaceutical for the therapy or prophylaxis of a thrombogenic disorder as well as to a method for producing a medicament and a diagnostic by employing the TAFI-Ile347 polymorphism.

Abstract: The present invention relates to pharmaceutical compositions and combinations for treating, preventing or managing heart failure and/or connected diseases therewith comprising 4{4-[3-(4-chloro-3-trifluoromethylphenyl)-ureido]-3-fluorophenoxy}-pyridine-2-carboxylic acid methylamide optionally combined with at least one additional therapeutic agent.

Abstract: A control element includes a switching element, an operating element for operating the switching element, a printed circuit board, and an electrically conductive sensor element of a capacitive proximity sensor integrated in the operating element. The electrically conductive sensor element is designed to be electrically conductively connected to the printed circuit board.

Abstract: The invention relates to a membrane filter unit for liquid or gaseous media, comprising a bundle of capillary membranes which are open on at least one front surface side and which are cast in an area which is close to the end of the open membrane ends, in a sealing layer forming a hardened head part. The open membrane ends protrude on the outer side of the sealing layer. The sealing layer is arranged on a spacer element which has a layer which is penetrated by the capillary membranes and which is non-permeable in relation to the casting material which hardens in order to form the sealing layer. The invention also relates to a method for the production of a membrane filter unit.

Abstract: A block piece for holding a spectacle lens blank has a basic body with a workpiece mounting face portion against which the workpiece can be blocked with a blocking material, and a clamping portion via which the blocked workpiece can be fixed in a machine/apparatus for processing it. The basic body is made substantially of a material having a defined low water absorption and/or is sealed to at least reduce outgassing of water moisture under vacuum conditions, so that the block piece can be used also in vacuum coating processes. Alternatively or in addition, the clamping portion is constructed to be clamped by forces directed essentially perpendicular to the radial direction to cancel out each other and not deform the basic body, and/or the workpiece mounting face portion is provided with a predetermined amount of prism.

Abstract: An airbag device for protecting a vehicle occupant in case of a crash, including at least one region that can be inflated with gas, which in the inflated state forms a gas cushion for a vehicle occupant to be protected in the form of a side airbag, at least a first material layer of the inflatable region extending in front of a lateral vehicle structure of a motor vehicle in the inflated state of the airbag device, and at least a second material layer of the inflatable region of the inflatable region, that opposes the first material layer in the inflated state of the airbag device, wherein at least one fastening flap is provided at the airbag device via which the airbag device can be fastened to a motor vehicle structure.

Abstract: The invention relates to a cyanide-free electrolyte composition for depositing a silver or silver alloy layer on a substrate as well as a method for depositing such layers with the help of said cyanide-free electrolyte composition. The electrolyte composition according to the invention comprises at least one silver ion source, a sulfonic acid and/or a sulfonic acid derivative, a wetting agent and a hydantoin. The silver or silver alloy layers deposited from such an electrolyte composition by means of the method according to the invention are dull and ductile.

Abstract: The present invention relates to a device for gassing a liquid (1), particularly for membrane facilities used in immersion operation, having a gas supply channel (2) and at least one gas lance (3) from which a gas flow exits in gassing operation. According to the present invention the gas lance (3) is connected to the gas supply channel (2) by means of at least one connection channel (5) comprising a first mouth area (8) on the side of the gas lance (3) and a second mouth area (8?) on the side of the gas supply channel (2) and generating as a throttle a flow pressure loss of the gas flow entering the gas lance (3). Below the first mouth area (8) an extension section (6) is provided, which adjoins the gas lance (3) and has an opening (7) below the first mouth area (8).

Abstract: The present application relates to the use of 1,4-diaryldihydropyrimidin-2-one derivatives of the formula (I) for the treatment and/or prophylaxis of pulmonary arterial hypertension and other types of pulmonary hypertension, and to the use thereof for the manufacture of medicaments for the treatment and/or prophylaxis of pulmonary arterial hypertension and other types of pulmonary hypertension.

Abstract: A membrane module for an immersed operation has a fiber bundle of hollow fiber membranes which are cast into a headpiece and in immersed operation are surrounded by a liquid to be filtered. The module has a permeate collection chamber connected to the headpiece with an outlet for permeate draining from the interior of the hollow fiber membranes, and a gas supply having a pipe guided by the headpiece. The pipe terminates in the interior of the fiber bundle and has a gas outlet for a gaseous medium, which after the transfer from the pipe to the liquid to be filtered rises as bubbles between the hollow fiber membranes. The fiber bundle is divided into sections and free spaces remain between the sections which extend from the pipe to the outer circumference of the headpiece and promote an inflow of the liquid into a foot area adjoining the headpiece.

Abstract: A membrane module for an immersed operation has a fibre bundle of hollow fibre membranes which are cast into a headpiece and in immersed operation are surrounded by a liquid to be filtered. The module has a permeate collection chamber connected to the headpiece with an outlet for permeate draining from the interior of the hollow fibre membranes, and a gas supply having a pipe guided by the headpiece. The pipe terminates in the interior of the fibre bundle and has a gas outlet for a gaseous medium, which after the transfer from the pipe to the liquid to be filtered rises as bubbles between the hollow fibre membranes. The fibre bundle is divided into sections and free spaces remain between the sections which extend from the pipe to the outer circumference of the headpiece and promote an inflow of the liquid into a foot area adjoining the headpiece.

Abstract: The invention describes the use of PPAR agonists of the formulae (I) or (II) for the treatment of congestive heart failure (CHF).